ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ET A and ETB receptor-induced renal vasoconstriction in vivo

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 2, 2008, Pages

  Thai, Tiffany L ^a,b   Arendshorst, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Afferent arteriole; Calcium signaling; CD38; Endothelin 1; Kidney

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; NICOTINAMIDE; NITRIC OXIDE; RUTHENIUM RED; RYANODINE RECEPTOR; SARAFOTOXIN S6C; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN 1; SARAFOTOXINS S6; VIPER VENOM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VASOCONSTRICTION; ANIMAL; BLOOD FLOW; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RENAL ARTERY; SPRAGUE DAWLEY RAT;

ADP-RIBOSYL CYCLASE; ANIMALS; ENDOTHELIN-1; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NIACINAMIDE; NITRIC OXIDE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REGIONAL BLOOD FLOW; RENAL ARTERY; RUTHENIUM RED; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VIPER VENOMS;

EID: 52449105192     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00512.2007     Document Type: Article

References (53)

1. Aarhus R, Graeff RM, Dickey DM, Walseth TF, Lee H. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem 270: 30327-30333, 1995.
2. Azevedo L, Janiszewski M, Soriano F, Laurindo F. Redox mechanisms of vascular cell dysfunction in sepsis. Endocr Metab Immune Disord Drug Targets 6: 159-164, 2006.
3. Badr K, Murray J, Breyer M, Takahashi K, Inagami T, Harris R. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 83: 336-342, 1989.
4. 2+ signaling: regulation of endothelin-induced contraction in peritubular smooth muscle cells. FASEB J 16: 697-705, 2002.
5. Boffa J, Arendshorst W. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 16: 117-124, 2005.
6. Boittin FX, Dipp M, Kinnear NP, Galione A, Evans AM. Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose. J Biol Chem 278: 9602-9608, 2003.
7. De Leon H, Garcia R. Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels. Reg Pep 60: 1-8, 1995.
8. de Toledo F, Cheng J, Liang M, Chini E, Dousa T. ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. Circ Res 86: 1153-1159, 2000.
9. Edwards R, Trizna W, Ohlstein E. Renal microvascular effects of endothelin. Am J Physiol Renal Fluid Electrolyte Physiol 259: F217-F221, 1990.
10. Endlich K, Hoffend J, Steinhausen M. Localization of endothelin ETA and ETB receptor-mediated constriction in the renal microcirculation of rats. J Physiol 497: 211-218, 1996.
11. 2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 292: F175-F184, 2007.
12. 2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 289: F1012-F1019, 2005.
13. 2+ release in preglomerular arterioles. Am J Physiol Renal Physiol 292: F1568-F1572, 2007.
14. Fernandez J, Deaglio S, Donati D, Beusan I, Corno F, Aranega A, Forni M, Falini B, Malavasi F. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents 12: 81-91, 1998.
15. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237, 2004.
16. Galione A, Churchill GC. Interactions between calcium release pathways: multiple messengers and multiple stores. Cell Calcium 32: 343-354, 2002.
17. Geiger J, Zou AP, Campbell WB, Li PL. Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries. Hypertension 35: 397-402, 2000.
18. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol Regul Integr Comp Physiol 271: R254-R261, 1996.
19. 2+ channels and cyclic ADP-ribose. J Cardiovasc Pharmacol 36: 758-763, 2000.
20. Hayashi M, Monkawa T, Yoshida T, Sasamura H, Matsumoto M, Inoue T, Mikoshiba K, Saruta T. Intracellular calcium concentration in the inositol trisphosphate receptor type 1 knockout mouse. J Am Soc Nephrol 10: 2094-2101, 1999.
21. Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 91: 1229-1235, 1995.
22. Hirata Y, Matsuoka H, Kimura K, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Sugimoto T, Yanagisawa M, Masaki T. Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats. Circ Res 65: 1370-1379, 1989.
23. Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130: 1885, 1992.
24. Inscho E, Imig J, Cook A, Pollock D. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 146: 1019-1026, 2005.
25. A receptors. Am J Physiol Renal Physiol 286: F660-F668, 2004.
26. B receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol 288: R1168-R1177, 2005.
27. Kinnear N, Boittin F, Thomas J, Galione A, Evans A. Lysosome-sarcoplasmic reticulum junctions: a trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J Biol Chem 279: 54319-54326, 2004.
28. Kohan DE. The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure. Curr Opin Nephrol Hypertens 15: 34-40, 2006.
29. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 83: 1762-1767, 1989.
30. Lanese D, Yuan B, McMurtry I, Conger J. Comparative sensitivities of isolated rat renal arterioles to endothelin. Am J Physiol Renal Fluid Electrolyte Physiol 263: F894-F899, 1992.
31. Lee H, Aarhus R. ADP-ribosyl cyclase: an enzyme that cyclizes NAD+ into a calcium mobilizing metabolite. Cell Regul 2: 203-209, 1991.
32. Luscher TF. Endothelin, endothelin receptors, and endothelin antagonists. Curr Opin Nephrol Hypertens 3: 92-98, 1994.
33. Ma J. Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle. J Gen Physiol 102: 1031-1056, 1993.
34. Ca channels are not activated in vivo under resting conditions and during agonist stimulation. Am J Physiol Regul Integr Comp Physiol 292: R345-R353, 2007.
35. Mitsui-Saito M, Kato I, Takasawa S, Okamoto H, Yanagisawa T. CD38 gene disruption inhibits the contraction induced by alpha-adrenoceptor stimulation in mouse aorta. J Vet Med Sci 65: 1325-1330, 2003.
36. Pollock D, Keith T, Highsmith R. Endothelin receptors and calcium signaling. FASEB J 9: 1196-1204, 1995.
37. Qiu C, Baylis C. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Kidney Int 55: 2390-2396, 1999.
38. Rabelink T, Kaasjager K, Boer P, Stroes E, Braam B, Koomans H. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int 46: 376-381, 1994.
39. Romano G, Giagu P, Favret G, Bartoli E. Effect of endothelin 1 on proximal reabsorption and tubuloglomerular feedback. Kidney Blood Press Res 23: 360-365, 2000.
40. Satriano J, Cunard R, Peterson OW, Dousa T, Gabbai FB, Blantz RC. Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation. Am J Physiol Renal Physiol 294: F795-F800, 2008.
41. Schiffrin EL. Vascular endothelin in hypertension. Vasc Pharmacol 43: 19-29, 2005.
42. Schneider MP, Boesen EI, Pollock DM. Contrasting actions of endothelin ETA and ETB receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 47: 731-759, 2007.
43. Schuber F, Lund F. Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites. Curr Mol Med 4: 249-261, 2004.
44. Shi Y, Lau C, Cupples W. Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors. Am J Physiol Regul Integr Comp Physiol 292: R354-R361, 2007.
45. 2+ release and vasoconstriction in small renal arteries. Microvasc Res 70: 65-75, 2005.
46. Thai T, Fellner S, Arendshorst W. ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo. Am J Physiol Renal Physiol 293: F1107-F1114, 2007.
47. Wendel M, Knels L, Kummer W, Koch T. Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney. J Histochem Cytochem 54: 1193-1203, 2006.
48. Woon E, Threadgill M. Poly(ADP-ribose)polymerase inhibition-where now? Curr Med Chem 12: 2373-2392, 2005.
49. 2+ mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 279: H873-H881, 2000.
50. 2+ release from vascular smooth muscle cell microsomes. Exp Biol Med 227: 36-44, 2002.
51. 2+ mobilizing second messenger-cyclic ADP-ribose. J Cell Mol Med 10: 407-422, 2006.
52. 2+ mobilization associated with lysosomes in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 291: H274-H282, 2006.
53. 2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries. Am J Physiol Heart Circ Physiol 290: H1172-H1181, 2006.